Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00873483 · ClinicalTrials.gov registry record · Phase 2
US Ovulation Inhibition Study in Obese Women
A Phase 2 study, sponsored by Bayer.
- Completed
- Registry status
- Phase 2
- Development phase
- 173
- Enrollment target
NCT00873483 is a Phase 2 study that has completed, run by Bayer. The registered enrollment target is 173 participants.
The verdict
NCT00873483, a Phase 2 study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 173 participants
- Enrollment target
Study Summary
Birth Control Patch Study
Interventions
- DRUG Ethinylestradiol/Gestodene (BAY86-5016)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 173 participants |
| Start Date | 2009-04-30 |
| Est. Completion | 2010-03-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00873483
The ClinicalTrials.gov registry entry for NCT00873483 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 173 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ethinylestradiol/Gestodene (BAY86-5016) is the first listed.
NCT00873483 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00873483 about?
NCT00873483 is a clinical study titled "US Ovulation Inhibition Study in Obese Women". Birth Control Patch Study
What is the current status of trial NCT00873483?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 173 participants. The study started on 2009-04-30. Estimated completion is 2010-03-03.
What interventions are being tested in trial NCT00873483?
The interventions under investigation include: Ethinylestradiol/Gestodene (BAY86-5016) (DRUG).
Who is sponsoring clinical trial NCT00873483?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.